NeoStem, Inc. “Cancer Treatment that Doesn’t Make You Sick”

Jun 25, 2014 (ACCESSWIRE via COMTEX) New York, NY / June 25, 2014 / NeoStem, Inc. (NASDAQ: NBS) today published a new blog post on The Chairman s Blog, written by the Company s CMO, Dr. Douglas Losordo. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends. In his most recent blog, Dr. Losordo discusses the potential of the Company s newly acquired cancer cell therapy to not only eliminate the toxicity of current cancer treatments, but also increase survival rates. Commenting on the five-year survival data for autologous melanoma immunotherapy targeting cancer stem cells presented at the American Society of Clinical Oncology Annual Meeting, he states, The data from the clinical study showed that the treated patients had more than a doubling of their two year survival. Read the full blog post from Dr. Losordo on TheChairmansBlog.com (http://www.thechairmansblog.com/n
http://bit.ly/1qwEOym